Trials / Completed
CompletedNCT00829140
To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake
A 56-Day , Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake in Overweight and Obese Patients (TULIP)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (estimated)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of lorcaserin on energy metabolism and food intake in obese and overweight patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | |
| DRUG | Lorcaserin 10mg BID |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2009-09-01
- Completion
- 2010-02-01
- First posted
- 2009-01-26
- Last updated
- 2019-09-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00829140. Inclusion in this directory is not an endorsement.